Malaria and artemisinin resistance: a bibliometric analysis

With roughly 50 % of the global population at risk for infection, malaria is one of the most serious public health problems in the world. This infection is caused by single-celled protozoa of the genus Plasmodium. By the turn of the century, the majority of antimalarial drugs were no longer effective against Plasmodium falciparum. However, one year after World Health Organization's final endorsement for the global use of ACTs, an appearance of artemisinin-resistant Plasmodium falciparum was seen in the border regions of Thailand and Cambodia and has since spread to other areas on the globe in subsequent years. The purpose of this work is to summarize the knowledge structure and trend of malaria and artemisinin resistance from 2012 to 2022. The VOS viewer application was used to bibliometrically analyze publications from 2012 to 2022. A total of 169 papers that discussed the keywords were used. VOS viewer application was used to produce maps based on the scientific data between the top authors and top terms in clusters. The research trend of artemisinin resistance and malaria was reported to be on the decline from 2019 to 2022. The bibliographic analysis offered an intellectual framework for the study area by identification of research groups and themes. The years with the most publications were 2015-2017, with 23 articles published each year. The most often used keywords in the research were artemisinin resistance (38 occurrences). The spread of artemisinin-resistant P. falciparum in significant regions of Southeast Asia threatens to destabilize malaria control globally. One of the most pressing global health concerns today is preventing artemisinin resistance from spreading to Africa, where the consequences for childhood mortality might be severe.

Analysis of re-emergence of Oncomelania snail in Sichuan Province from 2015 to 2019 / 上海预防医学

Objective To analyze the risk of re-emergence of Oncomelania snail(O.snail) from 2015 to 2019, in order to improve the effectiveness of snail control. Methods Collection of report forms and schistosomiasis surveillance data was carried out from 2015 to 2019, and analyzed retrospectively. Results The area of snail-emergence was 6 241.98 hm2 during 2015-2019, 44.29、4 610.18、813.92、446.09 and 327.50 hm2 respectively, for each corresponding year.Among the re-emergence areas, flat-ground subtype was 1 185.49 hm2(18.99%), hilly subtype was 2 536.58 hm2(40.64%), and mountain subtype was 2 519.91 hm2(40.37%).The top 5 cities with O.snail re-emergence areas were Liangshanzhou(2016), Ya′an(2016), Deyang(2016), Meishan(2016), and Meishan(2017).The top 5 disticts with O.snail re-emergence areas were Renshou, Puge, Lushan, Tianquan and Dechang. Conclusion The re-emergence of O.snail attributes to several factors, such as low quality of annual snail survey, unitary method of elimination and complexity of snail habit environment.Surveillance and supervision on the sources of infection and snail spreading should continue with exploration of new method in eliminating snails especially in hilly regions.

Pertussis, historia, hechos y situación actual / Pertussis, history, facts, and current situation / Pertussis, história, fatos e situação atual

Pertussis, tos convulsa o coqueluche son términos que se emplean como sinónimos para referirse a una infección respiratoria inmunoprevenible grave causada por la bacteria gram negativa denominada Bordetella pertussis. La mejor manera de prevenir la enfermedad es a través de la vacunación. Las primeras experimentaciones con vacunas comenzaron después de que Jules Bordet y Octave Gengou del Instituto Pasteur de Bruselas identificaran el agente etiológico en 1906. Estas primeras vacunas se hicieron a partir de células enteras del agente causal muertas por calor. La historia de las vacunas contra la enfermedad continuó desde aquel entonces con vacunas combinadas y luego con vacunas de componentes o acelulares. Su uso masivo desde los años 50 permitió una reducción muy marcada de la morbimortalidad asociada a la enfermedad. Sin embargo en el año 2008, se estimó que en el mundo se producen por año 16 millones de casos de los cuales 195.000 resultan ser fatales. Para el año 2014 esta estimación sobre el número de casos creció a 24,1 millones de casos en el año. El incremento del número de casos detectado en los últimos 20 años ha estado dirigiendo la mirada de la comunidad sanitaria y científica hacia la identificación de causas de esta nueva situación epidemiológica de pertussis para revisar e implementar estrategias de control más efectivas. Se ha logrado así un mejor reconocimiento de la enfermedad no solo entre los lactantes y los niños, sino también en los adolescentes y adultos. El mayor reconocimiento de que los niños mayores, los adolescentes y los adultos están en riesgo de contraer la enfermedad y que pueden transmitirla a los más vulnerables ha resaltado la necesidad de comprender mejor la inmunidad inducida por las vacunas y su duración. El rol de las vacunas y en particular de las vacunas acelulares constituidas por pocos inmunógenos en altas dosis sobre la selección de geno/fenotipos bacterianos más resistentes a la inmunidad inducida por las vacunas ha comenzado a visualizarse más claramente. La investigación en curso que utiliza herramientas novedosas sin dudas ha mejorado el conocimiento en general sobre esta patología, sin embargo la investigación debe continuar de forma de lograr una vigilancia más oportuna con terapias y vacunas de nueva generación más eficaces.

Pertussis or whooping cough is a preventable respiratory infectious disease caused by the gram-negative microorganism known as Bordetella pertussis. The best strategy to prevent pertussis is to get vaccinated. Vaccine development began just after Jules Bordet and Octave Gengou at Pasteur Institute from Brussels identified the etiologic agent of the disease in 1906. The first vaccine was formulated with heat-killed B. pertussis bacteria, which was later combined with tetanus and diphtheria toxoids (DTP). The second generation of pertussis vaccine was the acellular vaccine consisting in a few purified B. pertussis immunogens. The massive use of these vaccines since the 50s reduced the morbidity and mortality associated with the disease. However, in 2008 it was estimated that 16 million cases occurred by year with 195,000 deaths worldwide. For 2014, this estimation rised to 24.1 million cases per year. The increase in the number of cases detected in the last 20 years has been directing the attention of the health and scientific community towards the identification of causes of this new epidemiological situation of pertussis to review and implement more effective control strategies. This has achieved a better recognition of the disease not only among infants and children but also in adolescents and adults. The awareness that older children, adolescents and adults are at risk of contracting the disease and that they can transmit pertussis to the most vulnerable highlighted the need to better understand the immunity induced by pertussis vaccination and also the duration of such immunity. Another aspect that needs to be understood is that related to the selection pressure that the vaccines would be exerting (in particular the acellular vaccines) on the circulating bacterial population. In this sense, an increase in the prevalence of strains of B. pertussis that are more resistant to the immunity conferred by the vaccines has been detected. The ongoing research using innovative tools has undoubtedly improved the knowledge on pertussis; however research should continue to achieve a more timely surveillance with more effective new generation therapies and vaccines.

Pertussis, tosse convulsa ou coqueluche são termos que se utilizam como sinônimos para fazer referência a uma infecção respiratória imunoprevenível grave provocada pela bactéria gram negativa denominada Bordetella pertussis. A melhor forma de prevenir a doença é através da vacinação. As primeiras experimentações com vacinas começaram depois de que Jules Bordet e Octave Gengou do Instituto Pasteur de Bruxelas identificassem o agente etiológico em 1906. Estas primeiras vacinas foram feitas a partir de células inteiras do agente causal mortas por calor. A história das vacinas contra a doença continuou a partir de então com vacinas combinadas e depois com vacinas de componentes ou acelulares. O uso generalizado delas desde os anos 50 permitiu uma redução muito importante da morbimortalidade associada à doença. Entretanto, no ano 2008, a estimativa foi de 16 milhões de casos produzidos no mundo por ano dos quais 195.000 resultaram fatais. Para o ano 2014, essa estimativa sobre o número de casos cresceu a 24,1 milhões de casos no ano. O aumento do número de casos detectado nos últimos 20 anos dirigiu e dirige o foco da comunidade sanitária e científica para a identificação de causas dessa nova situação epidemiológica de coqueluche de forma de revisar e implementar estratégias de controle mais efetivas. Um melhor reconhecimento da doença foi assim possível, não só entre bebês e meninos, mas também nos adolescentes e adultos. O maior reconhecimento de que as crianças mais velhas, os adolescentes e os adultos estão em risco de contrair a doença e que pode transmiti-la aos mais vulneráveis tem salientado a necessidade de compreender melhor a imunidade induzida pelas vacinas e a duração delas. O papel das vacinas e, em particular, das vacinas acelulares constituídas por poucos imunógenos em altas doses sobre a seleção de genótipos/fenótipos bacterianos mais resistentes à imunidade induzida pelas vacinas tem começado a ser visualizado mais claramente. A pesquisa em andamento que utiliza ferramentas novas, sem dúvidas, tem melhorado o conhecimento em geral sobre essa patologia, contudo a pesquisa deve continuar de maneira de alcançar uma vigilância mais oportuna com terapias e vacinas de nova geração mais eficazes.

Enfermedades reemergentes: factores causales y vigilancia: [review] / Reemergent diseases: causal factors and surveillance: [revisión]

La emergencia y reemergencia de las enfermedades infecciosas posee muchos factores interrelacionados. La interconectividad global continúa en aumento a través del comercio, las relaciones culturales, económicas, políticas y las relaciones hombre- hombre y animal-hombre. Estas interrelaciones incluyen las accidentales y las programadas, donde se intercambian agentes microbianos además de su resistencia, lo que da pie a la emergencia de enfermedades emergentes y reemergentes. La solución a la expansión de estas entidades requiere un esfuerzo cooperativo de varias disciplinas mundiales. Se realizó una revisión bibliográfica que resume los factores que contribuyen a esta reemergencia.

The emergence and re-emergence of infectious diseases involves many interrelated factors. Global interconnectedness continues to increase with international travel and trade; economic, political, and cultural interactions; and human-to-human and animal-to-human interactions. These interactions include the accidental and deliberate sharing of microbial agents and antimicrobial resistance and allow the emergence of new and unrecognized microbial disease agents. Solutions to limiting the spread of emerging infectious diseases will require cooperative efforts among many disciplines and entities worldwide. This article defines emerging infectious diseases, summarizes historical background, and discusses factors that contribute to emergence.

Risk assessment of re-emerging Plasmodium falciparum on Ishigaki Island using a stochastic transmission model

On Ishigaki Island, <I>Plasmodium falciparum</I> and <I>Plasmodium vivax</I> epidemics occurred in 1945-1946 and were successfully suppressed. The epidemic re-emerged in 1949 because many settlers immigrated to the former endemic areas, but it terminated in 1961. The present study aimed at predicting an outbreak of a new epidemic based on the situation in which <I>P. falciparum</I> malaria patients stay on Ishigaki Island and also examined the re-emergence of the <I>P. falciparum</I> epidemic in 1951-1960 to determine the reliability of the model.<br>A stochastic transmission model of <I>P. falciparum</I> was constructed to detect a small number of infected persons. The seasonal fluctuation of the <I>Anopheles minimus</I> population obtained by observational data and meteorological data through statistical processing was introduced into the model.<br>Simulations were carried out to predict the risk of a new epidemic with scenarios in which the attribute of index patient, visiting season, and reduced inoculation rates of <I>An. minimus</I> were assumed. When an infected person visited the island in summer, a small number of patients with primary infections derived from the index patient appeared for all 1,000-iterations. On the other hand, when an infected person visited the island in winter, few or no patients with primary infections appeared for any of the 1,000-iterations because of the low mosquito density. In realistic conditions, the simulation results showed that there was little possibility of the occurrence of <I>P. falciparum</I> infection.

Re-emergence of Schistosomiasis in Dali City after the Criteria of Transmission Control Were Met / 中国寄生虫学与寄生虫病杂志

Objective To analyze the epidemic situation on schistosomiasis in five years after reaching the criteria of transmission control in 1995 in Dali City. . Methods. Epidemiological data of schistosomiasis during 1995-2000 were collected and analyzed. . Results . Stool positive rate in the population was increasing yearly, new cases of infection including cases under 14 years old were detected each year. Acute infection occurred during 1996-1998 consecutively. Stool positive rate in cattle was unstable. Snail-ridden area increased significantly in 1996 and spots with infected snails stayed at a higher level during 1997-2000. . Conclusion . Schistosomiasis in Dali city has been re-emerging though it was once deemed under transmission control. Possible reasons include a low drug-taking rate though distributed, frequent movement of cattle population, and less activity on snail control.